Abstract
Cyclosporin A (CsA) was first identified in the early 1970s by Dr J. F. Borel and colleagues of Sandoz Ltd as a compound in the culture broths of the fungi Tolypodadium inflatum and Cylindrocarpon lucidum that showed strong in vivo immunosuppressive activity in micer but was otherwise well tolerated. Their influential publication on the properties of CsA in 19761 led to successful clinical trials, and the drug is now in routine use in organ transplantation. It also shows promise in the prevention or treatment of some conditions with an autoimmune basis (discussed in subsequent chapters of this volume). It was very quickly apparent that CsA differed in its mechanism of action from pre-existing immunosuppressive drugs, in that at therapeutic concentrations it showed no general inhibition of cell proliferation and was not cytotoxic to lymphocytes.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Similar content being viewed by others
References
Borel, J. F., Feurerr C., Gubler, H. U. and Stahelin, H. (1976) Biological effects of cyclosporin A: a new antifymphocytic agent. Agents Actions, 6, 468–475
Von Wartburg, A. and Traber, R. (1986) Chemistry of the natural cyclosporin metabolites. Progr. Allergy, 38, 28–45
Wenger, R. M. (1986) Synthesis of Ciclosporin and analogues: structural and conformational requirements for immunosuppressive activity. Progr. Allergy, 38, 46–64
Hiestand, P. C., Gunn, H. C., Gales, J. M., Ryffel B. and Borel, J. F. (1985) Comparison of the pharmacological profiles of cyclosporine, (Nva2)-cyclosporine and (Val2)-dihydrocy-closporine. Immunology, 55, 249–255
Borel J. F. (1986) Ciclosporin and its future. Progr. Allergy, 38, 9–18
Wiesinger, D. and Borel, J. F. (1979) Studies on the mechanism of action of cyclosporin A. Immunobiology, 156, 454–463
Kay, J. E. and Benzie, C. R. (1983) Effects of cyclosporin A on the metabolism of unstimulated and mitogen-activated lymphocytes. Immunology, 49, 153–160
Kay, J. E. and Benzie, C. R. (1986) Lymphocyte activation by OKT3: cyclosporine sensitivity and synergism with phorbol ester. Immunology, 57, 195–199
Dongworth, D. W. and Klaus, G. G. B. (1982) Effects of cyclosporin on the immune system of the mouse. I. Evidence for a direct selective effect of cyclosporin A on B cells responding to anti-immunoglobulin antibodies. Eur. J. Immunol., 12, 1018–1022
Paavonen, T. and Hayry, P. (1980) Effect of cyclosporin A on T-dependent and T-independent immunoglobulin synthesis in vitro. Nature (Lond.), 287, 542–544
Van Buren, C. T., Kerman, R., Agostino, D., Payne, W., Flechner, S. and Kahan, B. D. (1982) The cellular target of cyclosporin A actions in humans. Surgery, 80, 167–173
Lafferty, K. J., Gill, R. and Babcock, S. (1986) Tolerance induction in adult animals. Progr. Allergy, 38, 247–257
Hess, A. D. and Colombani, P. M. (1986) Mechanism of action: in vitro studies. Progr. Allergy, 38, 198–221
Orosz, C C., Roopenian, D. C., Widmer, M. B. and Bach, F. H. (1983) Analysis of cloned T cell function. II. Differentia] blockade of various cloned T cell functions by cyclosporine. Transplantation, 36, 706–711
Damjanovich, S., Aszalos, A., Mulheim, S., Balazs, M. and Matyus, L. (1986) Cytoplasmic membrane potential of mouse lymphocytes is decreased by cyclosporins. Mol Immunol., 23, 175–180
Gelfand, E. W., Cheung, R. K. and Mills, C. B. (1987) The cyclosporins inhibit lymphocyte activation at more than one site. J. Immunol., 138, 1115–1120
Manca, F., Kurtkl, A. and Celada, F. (1985) Inhibition of the accessory function of murine macrophages in vitro by cyclosporine. Transplantation, 39, 644–649
Varey, A-M., Champion, B. R. and Cooke, A. (1986) Cyclosporine affects the function of antigen-presenting cells. Immunoloy, 57, 111–114
Knight, S. C., Balfour, B., O’Brien, J. and Buttifant, L. (1986) Sensitivity of veiled (dendritic) cells to cyclosporine. Transplantation, 41, 96–100
Knight, S. C. and Bedford, P. A. (1987) Effects of cyclosporine and retinoic acid on dendritic cell function. Transplant. Proc., 19, 320–323
Knight, S. C., Roberts, M., Macatonia, S. E. and Edwards, A. J. (1988) Blocking of acquisition and presentation of antigen by dendritic cells with cyclosporine. Transplantation (Suppl), 46, 48S–53S
Kay, J. E. and Benzie, C. R. (1984) Rapid loss of sensitivity of mitogen-induced lymphocyte activation to inhibition by cyclosporin A. Cell. Immunol., 87, 217–224
Bunjes, D., Hardt, C., Rollinghoff, M. and Wagner, H. (1981) Cyclosporin A mediates immunosuppression of primary cytotoxic T cell responses by impairing the release of interleukin-1 and interleukin-2. Eur. J. Immunol., 11, 657–661
Wang, B. S., Heacock, E. H., Collins, K. H., Hutchinson, I. F., Tilney, N. L. and Mannick, J. A. (1981) Suppressive effects of cyclosporin A on the induction of alloreactivity in vitro and in vivo. J. Immunol., 127, 89–93
O’Garra, A., Warren, D. J., Holman, M., Popham, A. M., Sanderson, C. J. and Klaus, G. G. B. (1986) Effects of cyclosporine on responses of murine B cells to T cell-derived lymphokines. J. Immunol., 137, 2220–2224
Isakov, N., Maey, M. I., Scholz, W. and Altman, A. (1987) T lymphocyte activation: the role of protein kinase C and the bifurcating inositol phospholipid signal transduction pathway. Immunol Rev., 95, 89–111
King, S. (1988) An assessment of phosphoinositide hydrolysis in antigenic signal transduction in lymphocytes. Immunology, 65, 1–7
Zilberman, Y., Howe, L. R., Moore, J. P., Hesketh, T. R. and Metcalfe, J. G (1987) Calcium regulates inositol 1,3,4,5-tetrakisphophate production in lysed thymocytes and in intact cells stimulated with concanavalin A. EMBO J., 6, 957–962
Truneh, A., Albert, F., Golstein, P. and Schmitt-Verhulst, A-M. (1985) Early steps of lymphocyte activation bypassed by synergy between calcium ionophores and phorbol ester. Nature (Lond.), 313, 318–320
Kaibuchi, K., Takai, T. and Nishizuka, Y. (1985) Protein kinase C and calcium ion in mitogenic response of macrophage-depleted human peripheral lymphocytes. J. Biol Chem., 260, 1366–1369
Rosoff, P. M., Savage, N. and Dinarello, C. A. (1988) Interleukin-1 stimulates diacylglycerol production in T lymphocytes by a novel mechanism. Cell, 54, 73–81
Bijsfcerbosch, M. K. and Klaus, G. G. B. (1985) Cyclosporine does not inhibit mitogen-induced inositol phospholipid degradation in mouse lymphocytes. Immunology, 56, 435–440
Mizushima, Y., Kosaka, H., Sakuma, S., Kanda, K., Itoh, K., Osugi, T., Mizushima, A., Hamaoka, T., Yoshida, H., Sobue, K. and Fujiwara, H. (1987) Cyclosporin A inhibits late steps of T lymphocyte activation after transmembrane signalling. J. Biochem., 102, 1193–1201
Palacios, R. (1982) Concanavalin A triggers T lymphocytes by directly interacting with their receptors for activation. J. Immunol., 128, 337–342
Kay, J. E., Meehan, R. T. and Benzie, C. R. (1983) Activation of T lymphocytes by 12-O-tetradecanoylphorbol-13-acetate is resistant to inhibition by cyclosporin A. Immunol Lett., 7, 151–156
Kay, J. E., Benzie, C. R. and Borghetti, A. F. (1983) Effect of cyclosporin A on lymphocyte activation by the calcium ionophore A23187. Immunology, 50, 441–46
Szamel, M., Martin, A. and Resch, K. (1985) Inhibition of lymphocyte activation by cyclosporin A: interference with the early activation of the membrane phospholipid metabolism in rabbit lymphocytes stimulated with concanavalin A, anti-rabbit immunoglobulin or the Ca2+ ionophore A23187. Cell. Immunol., 93, 239–249
Klaus, G. G. B. (1987) Cyclosporin as a probe for different modes of lymphocyte activation. Ann. Inst. Pasteur/Immunol., 138, 626–628
Metcalfe, S. M. (1984) Cyclosporine does not prevent cytoplasmic calcium changes associated with lymphocyte activation. Transplantation, 38, 161–164
Wiskodi R., Weiss, A., Imboden, J., Kamin-Lewis, R. and Stobo, J. (1985) Activation of a human T cell line: a two stimulus requirement in the pre-translational events involved in the coordinate expression of interteukin-2 and gamma interferon genes. J. Immunol., 134, 1599–1603
Rosoff, P. M and Terres, G. (1986) Cyclosporin A inhibits Ca2+ dependent stimulation of the Na+/H+ antiport in human T cells. J. Cell Biol., 103, 457–463
Manger, B., Hardy, K. J., Weiss, A. and Stobo, J. D. (1986) Differential effect of cyclosporin A on activation signalling in human T cell lines. J. Clin. Invest., 77, 1501–1506
Kay, J. E., Benzie, C. R. and Gudgeon, M. C. Unpublished data.
Granelli-Piperno, A., Artdrus, L. and Steinman, R. M. (1986) Lymphokine and non-lymphokine mRNA levels in stimulated human T cells. J. Exp. Med., 163, 922–937
Goodier, M. R. and Kay, J. E. Unpublished data.
Miyawaki, T., Yachie, A., Ohzeki, S., Nagaoki, T. and Taniguchi, N. (1983) Cyclosporin A does not prevent expression of Tac antigen, a probable TCGF receptor molecule, on rnitogen-stimulated human T cells. J. Immunol., 130, 2737–2742
Kronke, M., Leonard, W. J., Depper, J. M., Arya, S. K., Wong-Staal, F., Gallo, R. C., Waldmann, T. A. and Greene, W. C. (1984) Cyclosporin A inhibits T-cell growth factor gene expression at the level of mRNA transcription. Proc. Natl Acad. Sci. USA, 81, 5214–5218
Larsson, E-L. (1980) Cyclosporin A and dexamethasone suppress T cell responses by selectively acting at distinct sites of the triggering process. J. Immunol., 124, 2828–2833
Lillehoj, H. S., Malek, T. R. and Shevach, E. M. (1984) Differential effect of cyclosporin A on the expression of T and B lymphocyte activation antigens. J. Immunol, 133, 244–250
Reed, J. C., Abidi, A. H., Alpers, J. D., Hoover, R. G., Robb, R. J. and Nowell, P. C. (1986) Effect of cyclosporin A and dexamethasone on interleukin 2 receptor gene expression. J. Immunol., 137, 150–154
Aiello, F. B., Maggiano, N., Larocca, L. M., Piantelli, M. and Musiani, P. (1986) Inhibitory effect of cyclosporin A on the OKT3-induced peripheral blood lymphocyte proliferation. Cell. Immunol., 97, 131–139
Szamel, M., Berger, P. and Resch, K. (1986) Inhibition of T lymphocyte activation by cyclosporin A: interference with the early activation of plasma membrane phospholipid metabolism. J. Immunol., 136, 264–269
Fidelius, R. K., Laughter, A. R, Tworney, J. J., Taffet, S. M. and Haddox, M. K. (1984) The effect of cyclosporine on ornithine decarboxylase induction with mitogens, antigens and lymphokines. Transplantation, 37, 383–389
Bunjes, D., Hardt, C., Rollinghoff, M. and Wagner, H. (1981) Cyclosporin A mediates immunosuppression of primary cytotoxic T cell responses by impairing the release of interleukin 1 and interleukin 2. Eur. J. Immunol., 11, 657–661
Kaufmann, Y., Chang, A. E., Robb, R. J. and Rosenberg, S. A. (1984) Mechanism of action of cyclosporin A: inhibition of lymphokine secretion studied with antigen-stimulated T cell hybridomas. J. Immunol., 133, 3107–3111
Granelli-Piperno, A., Inaba, K. and Steinman, R. (1984) Stimulation of lymphokine release from T lymphoblasts. Requirement for mRNA synthesis and inhibition by cyclosporin A. J. Exp. Med., 160, 1792–1802
Elliott, J. F., Lin, Y., Mizel, S. B., Bleackley, R. C., Harnish, D. G. and Paetkau, V. (1984) Induction of interleukin 2 mRNA inhibited by cyclosporin A. Science, 226, 1439–1442
Herold, K. C., Lancki, D. W., Moldwin, R. L. and Fitch, F. W. (1986) Immunosuppressive effects of cyclosporin A on cloned T cells. J. Immunol., 136, 1315–1321
Kalman, V. K. and Klimpel, G. R. (1983) Cyclosporin A inhibits the production of gamma interferon but does not inhibit production of virus-induced interferon alpha and beta. Cell. Immunol., 78, 122–129
Palados, R., Martinez-Maza, O. and De Ley, M. (1983) Production of human immune interferon studied at the single cell level. Origin, evidence of spontaneous secretion and effect of cydosporin A. Eur. J. Immunol., 13, 221–225
Reem, G. H., Cook, L. A. and Vilcek, J. (1983) Gamma interferon synthesis by human thymocytes and T lymphocytes inhibited by cyclosporin A. Science, 221, 63–65
Bickel, M., Tsuda, H., Amstad, P., Evequoz, V., Mergenhagen, S. E., Wahl, S.M. and Piuznik, D. H. (1987) Differential regulation of colony simulating factors and interleukin 2 production by cyclosporin A, Proc. Natl. Acad. Sci. USA, 84, 3274–3277
Granelii-Piperho, A. (1988) Effects of cyclosporin A on T lymphocytes and accessory cells from human blood. Ahshr. 9th European Immunology Congress (Rome), p. 230
Shaw, J., Meerovitch, K., Elliott, J. F., Bleackley, R. C. and Paetkau, V. (1987) Induction, suppression and superinduction of lymphokine mRNA in T lymphocytes. Mol. Immunol., 24, 409–419
Brack, C., Mattaj, I. W., Gautschi, J. and Cammisuli, S. (1984) Cyclosporin A is a differential inhibitor of eukaryotic RNA polymerases. Exp. Cell Res., 151, 314–321
Andrus, L. and Lafferty, K. J. (1982) Inhibition of T cell activity by cyclosporin A. Scand. J. Immunol., 15, 449–458
Thomson, A. W., Moon, D. K., Geczy, G L. and Nelson, D. S. (1983) Cyclosporin A inhibits lymphokine production, but not responses of macrophages to lymphokines. Immunology, 48, 291–299
Helin, H. J. and Edgington, T. S. (1984) Cyclosporin A regulates monocyte/macrophage effector functions by affecting instructor T cells. Inhibition of monocyte procoagulant response to allogeneic stimulation. J. Immunol., 132, 1074–1076
Havele, C. and Paetkau, V. (1988) Cyclosporme blocks the activation of antigen-dependent cytotoxic T lymphocytes directly by an IL-2-independent mechanism. J. Immunol., 140, 3303–3308
Bendtzen, K. and Dinarello, C. A. (1984) Mechanism of action of cyclosporin A. Effect on T-cell-binding of interleukin 1 and antagonizing effect of insulin. Scand. J. Immunol., 20,43–51
Galatowicz, G., Benzie, C. R., Kay, J. E. and Soos, M. (1986) The role of insulin in lymphocyte activation. Biochem. Soc. Trans., 14, 326
LeGrue, S. J., Friedman, A. W. and Kahan, B. D. (1983) Binding of cyclosporine by human lymphocytes and phospholipid vesicles. J. Immunol., 131, 712–718
Koponen, M. and Loor, F. (1983) Cytoplasmic lipid droplets as the possible eventual cellular fate of active forms of cyclosporin. Exp. Cell Res., 149, 499–512
Merker, M. M. and Handschumacher, R. E. (1984) Uptake and nature of the intracellular binding of cyclosporin A in a murine thymoma cell line, BW5147. J. Immunol., 132, 3064–3070
Handschumacher, R. E., Harding, M W., Rice, J., Drugge, R. J. and Speicher, D. W. (1984) Cyclophilin: a specific cytosolic binding protein for cyclosporin A. Science, 226, 544–547
Koletsky, A. J., Harding, M. W. and Handschumacher, R. E. (1986) Cyclophilin: distribution and variant properties in normal and neoplastic tissues, J. Immunol., 137, 1054–1059
Haendler, B., Hofer-Warbinek, R. and Hofer, E. (1987) Complementary DNA for human T-cell cyclophilin. EMBO J., 6, 947–950
Harding, M. W., Handschumacher, R. E. and Speicher, D. W. (1986) Isolation and amino acid sequence of cyclophilin. J. Biol. Chem., 261, 8547–8555
Danielson, P. E, Forss-Petter, S., Brow, M. A, Calavetfca, L., Douglass, J., Milner, R. J. and Sutcliffe, J. G. (1988) plBl5: a cDNA clone of the rat mRNA encoding cyclophilin. DNA, 7, 261–267
Gschwendt, M., Kittstein, W. and Marks, F. (1988) Sequence homology between cyclophilin and elongation factor 2. Biochem. J., 256, 1061
Colombani, P. M., Robb, A. and Hess, A. D. (1985) Cyclosporin binding to calmodulin: a possible site of action on T lymphocytes. Science, 228, 337–339
Hait, W. N., Harding, M. W. and Handschumacher, R. E. (1986) Calmodulin, cyclophilin and cyclosporin A. Science, 233, 987–988
LeGrue, S. J., Turner, R., Weisbrodt, N. and Dedman, J. R. (1986) Does the binding of cyclosporine to calmodulin result in immunosuppression? Science, 234, 68–71
Gudgeon, M. C., Benzie, C. R. and Kay, J. E. (1986) Role of Ca2+ and calmodulin in the inhibition of lymphocyte activation by cyclosporine. Biochem. Soc. Trans., 14, 1050–1051
Gudgeon, M. C. (1986) Studies on the mechanism of action of cyclosporin A. D.Phil, thesis, University of Sussex, pp. 136–149
Hess, A. D. and Colombani, P. N. (1987) Cyclosporin-resistant and -sensitive T lymphocyte subsets. Ann. Inst. Pasteur/Immunol, 138, 606–611 & 648–650
Larson, D. F. (1986) Mechanism of action: antagonism of the prolactin receptor. Progr. Allergy, 38, 222–238
Hiestand, P. G, Melder, P., Nordmann, R., Glieder, A. and Permmongkol, C. (1986) Prolactin as a modulator of lymphocyte responsiveness provides a possible mechanism of action for cyclosporine. Proc.. Natl Acad. Sci. USA, 83, 2599–2603
Daniel, T. O and Ives, H. E. (1987) Cyclosporin A inhibits kinase C-independent activation of the Na+/H+ exchange by platelet-derived growlh factor and vanadate. Biochem. Biophys. Res. Commun., 145, 111–117
Slater, L. M., Sweet, P., Stupecky, M. and Gupta, S. (1986) Cyclosporin A reverses vincristine and daunorubicin resistance in acute lymphatic leukaemia in vifro. J. Clin. Invest., 77, 1405–1408
Nicchitta, G V., Kamoun, M. and Williamson, J. R. (1985) Cyclosporine augments receptor-mediated cellular Ca2+ fluxes in Isolated hepatocytes. J. Biol. Ckem., 260, 13613–13618
Pfeilschifter, J. and Ruegg, U. T. (1987) Cyclosporin A augments angiotensin II-stimulated rise in intracellular free calcium in vascular smooth muscle cells. Biochem. J., 248, 883–887
Fournier, N., Ducet, G. and Crevat, A. (1987) Action of cyclosporine on mitochondrial calcium fluxes. J. Bioenerg. Biomembr., 19, 297–303
Crornpton, M., Ellinger, K and Costi, A. (1988) Inhibition by cyclosporin A of a Ca2+-dependent pore in heart mitochondria activated by inorganic phosphate and oxidative stress. Biochem. J., 255, 357–360
Gschwendt, M., Kittstein, W. and Marks, F. (1988) Effect of tumor promoting phorbol ester TPA on epidermal protein synthesis: stimulation of an elongation factor 2 phosphatase activity by TPA in vivo. Biochem. Biophys. Res. Commun., 153, 1129–1135
Chisholm, P. M., Drayson, M. T., Cox, J. H. and Ford, W. L. (1985) The effects of cyclosporin on lymphocyte activation in a systemic graft-vs.-host reaction. Eur. J. Immunol., 15, 1054–1059
Klaus, G. G. B. and Chisholm, P. M. (1986) Does cyclosporine act in vivo as it does in vitro? Immunol. Today, 7, 101–103
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1989 Kluwer Academic Publishers
About this chapter
Cite this chapter
Kay, J.E. (1989). Inhibitory effects of cyclosporin A on lymphocyte activation. In: Thomson, A.W. (eds) Cyclosporin. Springer, Dordrecht. https://doi.org/10.1007/978-94-009-0859-8_1
Download citation
DOI: https://doi.org/10.1007/978-94-009-0859-8_1
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-010-6874-1
Online ISBN: 978-94-009-0859-8
eBook Packages: Springer Book Archive